Stay updated on PI3K/Akt Suppression vs MK-3475 in Glioblastoma Clinical Trial
Sign up to get notified when there's something new on the PI3K/Akt Suppression vs MK-3475 in Glioblastoma Clinical Trial page.

Latest updates to the PI3K/Akt Suppression vs MK-3475 in Glioblastoma Clinical Trial page
- Check4 days agoChange DetectedLocations sections were added, listing study sites in Massachusetts, Texas, Lower Silesian Voivodeship, and Ulster; the revision tag updated to v3.3.3.SummaryDifference0.5%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe page now shows Revision: v3.3.2 replacing Revision: v3.3.1; no other study content, eligibility criteria, contacts, locations, or outcomes appear to have changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check33 days agoChange DetectedRevision label updated from v3.2.0 to v3.3.1; this appears to be a versioning change that does not alter study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check41 days agoChange DetectedThe top banner about potential updates due to a lapse in government funding and links to cc.nih.gov and opm.gov was removed.SummaryDifference0.4%

- Check55 days agoChange DetectedScreenshots show the Study Details page content and layout largely unchanged; there are no updates to core data such as status, enrollment, locations, or eligibility. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check83 days agoChange DetectedKey updates: version bump to v3.2.0 and an important government-operating-status notice; the previous v3.1.0 reference was removed. Overall, user-facing status and versioning information were updated. If no other content changed, this is a targeted update to status and versioning.SummaryDifference3%

Stay in the know with updates to PI3K/Akt Suppression vs MK-3475 in Glioblastoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PI3K/Akt Suppression vs MK-3475 in Glioblastoma Clinical Trial page.